This week: Consider how your DNA could make you less secure, learn about how a controversial doctor from Massachusetts General Hospital is helping to improve diabetes treatment, and get all the details of the next big Hacakthon in San Francisco!
The advancement of sequencing technology has had the singe biggest effect on genomics research. As it develops further, so does the scope of genomic research and applications.
DNA is often referred to as the blueprint of life, however, scientists have for the first time discovered a microbe that uses two different translations of the DNA code at random.
George Church talks about his disappointment with the Human Genome Project, the blistering price/performance improvements in both DNA synthesis and sequencing, and CRISPR’s strength and weaknesses, in addition to the improvements he hopes to see in its successors.
The study of viral ecology is taking major leaps forward with the use of long-read sequencing and viral metagenomics. On this webinar we discuss how MinION technology is bringing scientists closer to high-throughput single-virus genomics from environmental samples.
People’s medical and health history might become more than just a blueprint for doctor’s actions, now that blockchain start-up Nebula Genomics, and Hong Kong-based Longenesis are partnering up.
Whilst biotech companies are rushing to bring transformative gene therapies to market, states are too slow on adopting screening tests for genetic diseases that are, increasingly, treatable.
Michigan based researchers identify long noncoding RNA transcript as important molecule in prostate cancer progression. If you’re new to noncoding RNAs and cancer, this might be useful to read first!